Good question!
In Teva's case, the terms were known (and in fact had been watered down from the original). MSB has stated that the termination was in accordance with the agreement which only basically allowed for termination for lack of efficacy or slow recruitment (this info is publicly available from the US SEC website). So Teva did not like the tech - indeed it is interesting that they specifically amended the agreement to include this termination provision which was not in the original agreement.
Mallinckrodt and Celgene were both agreements to agree - so could be either. Nevertheless, even if it was because they did not like the terms that says MSB's expectations are set too high, the technology is not worth what they think it is.
Novartis was pre-agreed - so like Teva they did not like the tech.
- Forums
- ASX - By Stock
- OTAT Meeting
Good question!In Teva's case, the terms were known (and in fact...
-
-
- There are more pages in this discussion • 9 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
96.0¢ |
Change
0.025(2.67%) |
Mkt cap ! $1.096B |
Open | High | Low | Value | Volume |
95.0¢ | 96.5¢ | 94.0¢ | $1.231M | 1.291M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 94461 | 95.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
96.0¢ | 61151 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
4 | 94461 | 0.950 |
6 | 59977 | 0.945 |
9 | 154571 | 0.940 |
4 | 44875 | 0.935 |
5 | 92633 | 0.930 |
Price($) | Vol. | No. |
---|---|---|
0.960 | 61151 | 6 |
0.965 | 46785 | 5 |
0.970 | 48228 | 6 |
0.975 | 64461 | 2 |
0.980 | 31269 | 3 |
Last trade - 16.10pm 12/09/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |